Overview

Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer

Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
The efficacy and safety of the use of Camrelizumab combined with Apatinib
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Zhongshan Hospital Xiamen University
Treatments:
Apatinib